BMO Capital Maintains Outperform on Celestica, Raises Price Target to $450

Benzinga Newsdesk www.benzinga.com Positive 89.1%

Neg 0% Neu 0% Pos 89.1%

BMO Capital analyst Thanos Moschopoulos maintains Celestica (NYSE:CLS) with a Outperform and raises the price target from $370 to $450.